Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel Plans New Facility in Scotland to Flesh Out PGx Play

NEW YORK, Feb. 23 (GenomeWeb News) - Tepnel Life Sciences today announced it has bought 1.7 acres in Livingston, Scotland to construct a dedicated pharmaceutical, protein, and genomic facility.

 

The facility will allow the company to expand its pharmacogenomics capabilities to include high-throughput genotyping and other genomic techniques, said Tepnel in a statement.

 

Tepnel is a UK-based molecular diagnostics company with laboratories in the US, UK, and France.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.